Evidence map›Paper›PMID 34662429›Full record

ArticleActa psychiatrica Scandinavica2022

Real-world evidence of age-independent electroconvulsive therapy efficacy: A retrospective cohort study.

James Luccarelli, Thomas H McCoy, Stephen J Seiner, Michael E Henry

Open access · greenAbstract read
In one paragraph

Article in Acta psychiatrica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?The international journal of neuropsychopharmacology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. The Effects of Baseline Impaired Global Cognitive Function on the Efficacy and Cognitive Effects of Electroconvulsive Therapy in Geriatric Patients: A Retrospective Cohort Study.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2022
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James LuccarelliDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-1606-3917
Thomas H McCoyDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Stephen J SeinerDepartment of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA.
Michael E HenryDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard University · US

Funding

Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar DisorderR01MH120991 · NIMH · MCLEAN HOSPITAL · PI BERRETTA, SABINA, MCCARROLL, STEVEN ANDREW · 2020 to 2024
$4.0M
A Transdiagnostic Assessment of Electroconvulsive Therapy Modulation of Anhedonia and Reward circuitry: Targets, Biomarkers and Predictors of ResponseR01MH112737 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI CAMPRODON, JOAN A · 2017 to 2021
$3.8M
Fostering Research Mentorship & Training during Psychiatry Residency SupplementR25MH094612 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI FAVA, MAURIZIO, GREENFIELD, SHELLY F. · 2011 to 2022
$2.3M
NIMH NIH HHS R01 MH112737NIMH NIH HHS R01 MH120991NIMH NIH HHS R25 MH094612
6 · The paper itself

Abstract

objectivesElectroconvulsive therapy (ECT) is an effective treatment for depressive disorders and approved for use in adolescents and adults, but it is unclear whether efficacy or cognitive side effect burden differs with age or if effectiveness in usual clinical practice matches that in prospective studies. We examined the effects of ECT on depression and cognition in a large clinical cohort.

methodsA retrospective cohort study of patients ages 16 and older receiving ECT between 2011 and 2020 and who were evaluated with the Quick Inventory of Depressive Symptomatology (QIDS), the Behavior and Symptom Identification Scale-24 (BASIS-24), and the Montreal Cognitive Assessment (MoCA) at baseline and after treatment #10.

resultsAmong 1698 patients, ECT was associated with a decrease in depression symptoms (QIDS reduction from 17.1 ± 4.9 to 10.1 ± 5.2) and improvement in self-reported mental health (BASIS-24 scores improved from 1.92 ± 0.55 to 1.17 ± 0.60). There was a reduction in MoCA scores from 25.8 ± 3.1 to 25.4 ± 3.1. In multivariate models, age was not associated with a differential QIDS or BASIS-24 response, but older age was associated with a lesser reduction in MoCA.

conclusionAmong 1698 patients aged 16 and older, ECT was associated with improvement in depression and overall self-reported mental health, with a slight decrease in cognition. Age was not associated with changes in efficacy, but older age was associated with a lesser cognitive change as measured by the MoCA. These results provide normative data of real-world effectiveness of ECT, and add further support to its utility in patients with severe psychiatric illness.

Indexed as

Electroconvulsive TherapyAdolescentAdultAgedCognitionHumansMental Status and Dementia TestsProspective StudiesRetrospective StudiesTreatment Outcomecohort studieselectroconvulsive therapytreatment outcome

Identifiers

PMID34662429
PMCPMC8709695
OpenAlexW3207822871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.